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With increasing demand for donor organs for trans-
plantation, machine perfusion (MP) promises to be a
beneficial alternative preservation method for donor
livers, particularly those considered to be of subopti-
mal quality, also known as extended criteria donor
livers. Over the last decade, numerous studies
researching MP of donor livers have been published
and incredible advances have been made in both
experimental and clinical research in this area. With
numerous research groups working on MP, various
techniques are being explored, often applying differ-
ent nomenclature. The objective of this review is to
catalog the differences observed in the nomenclature
used in the current literature to denote various MP
techniques and the manner in which methodology is
reported. From this analysis, we propose a standard-
ization of nomenclature on liver MP to maximize
consistency and to enable reliable comparison and
meta-analyses of studies. In addition, we propose a
standardized set of guidelines for reporting the
methodology of future studies on liver MP that will
facilitate comparison as well as clinical implementa-
tion of liver MP procedures.
Abbreviations: MP, machine perfusion; PRISMA,
Preferred Reporting Items for Systematic Reviews
and Meta-Analyses; SCS, static cold storage
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Introduction
In an effort to meet the demand for donor organs needed
for transplantation, livers considered to be of suboptimal
quality and function are increasingly being transplanted.
Given the increased vulnerability of these organs and the
potential injury incurred during procurement and storage/
transportation, machine perfusion (MP) is a promising
alternative to static cold storage (SCS), the current stan-
dard of care in donor liver preservation. Following the first
successful series of extra-corporeally perfused canine liver
grafts performed by Brettschneider and Starzl et al. in
1967 (1), MP has been explored as a method to achieve
the preservation of donor livers under conditions simulat-
ing normal in vivo physiology in an attempt to minimize
ischemia-related injury associated with SCS. Research into
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MP has established three major benefits: the capability to
preserve donor organs while providing them with oxygen
and nutrients at various temperatures (optimal and pro-
longed preservation); the ability to recondition and opti-
mize the function of donor organs, particularly extended
criteria organs, with, for instance, oxygen perfsufflation,
de-fatting techniques for steatotic livers and pharmaceuti-
cal intervention (organ resuscitation and function recov-
ery); and lastly, to provide the possibility of testing the
function and viability of the organ prior to transplantation
(ex situ viability testing) by MP at 37°C.
With the number of publications on liver MP to date
exceeding 500, the last 10 years has seen an incredible
advancement in both experimental and clinical research
into donor liver MP. Several groups have been exploring
different methods of MP with the major technique differ-
ences relating to the temperatures used and the provision
of oxygen and whether the technique is flow or pressure
controlled. Given that MP is a nascent technology with
many technical aspects continuing to be explored, adapted
and improved, the publications on MP have exhibited great
discrepancies. These include the nomenclature used to
describe the different MP techniques (abbreviations
included), the temperatures considered to be hypo-, sub-
normo, or normothermic and the manner in which certain
details of the methodology are reported. The absence of
standardized nomenclature and guidelines for reporting
technical details pertaining to MP gives rise to the rela-
tively large variation that exists among studies. This makes
it difficult to compare different studies, perform meta-ana-
lyses and, in some cases, attempt to reexecute the
methodology used.
With the number of clinical studies on MP of donor liv-
ers rapidly increasing, it is important that a consensus
is reached on the nomenclature applied and which nec-
essary aspects of the methodology should be included
in a paper. The objective of this review is to catalog the
differences observed in the nomenclature used in the
current literature to denote various techniques of liver
MP and the manner in which the methodology is
described. From our analysis, we aim to address these
discrepancies, propose recommendations for nomencla-
ture and develop a standardized set of guidelines for
the reporting methodology for future studies on MP of
donor livers.
Methods
Literature search strategy
A comprehensive literature search for all published articles regarding MP
of donor livers was performed using the PubMed, EMBASE, MEDLINE,
Web of Science, and Cochrane Library databases. The final date of the
search was February 17, 2015. To ensure all potentially relevant articles
were included in the search, no specific date limits were set. The search
was conducted using the medical subject heading (MeSH) terms and
Emtree keywords “machine perfusion, machine preservation, liver
transplantation, and hepatic transplantation” combined with free text
terms regarding machine perfusion of donor livers such as “hypothermic,”
“normothermic,” and “subnormothermic.”
Selection criteria and data collection
Study selection was performed independently by two authors (S.A.K and
R.J.P.) in a standardized fashion using the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) method (2). Study
inclusion was carried out in three phases. An initial title search was car-
ried out whereby relevant titles were screened and studies whose titles
were unrelated to the aims of this review were excluded. The abstracts
of the remaining studies were then acquired and independently assessed
for eligibility. Full papers of the abstracts regarded as potentially eligible
were retrieved and underwent complete review and assessment until a
final compilation of articles was made. For articles in which an inconsis-
tency between the two authors occurred, a discussion about these arti-
cles was held to reach to a consensus. Figure 1 illustrates the study
selection procedure and the inclusion and exclusion criteria.
Inclusion criteria:
• All articles on machine perfusion of donor livers
• Fully accessible articles written in English and published in scientific
journals
• Human and animal studies
Article titles identified in 
all databases n= 2265
Irrelevant titles 
excluded n= 1406
Abstracts
n= 859
Duplicates excluded n= 287
Irrelevant abstracts excluded n=
291
Full papers 
n= 254
Unfound full articles n=27
Irrelevant articles n= 86
Reviews n= 25
Non-English n= 16
Included articles 
n=127
Figure 1: Flow chart illustrating study selection and inclu-
sion procedure. Irrelevant titles included studies mainly involv-
ing in vivo perfusion (and not machine perfusion), in vitro cell
studies, follow-up studies on MP or studies involving analysis of
data from studies on MP of donor livers without including the
MP procedure description in the methodology.
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Exclusion criteria:
• Irrelevant to title and objective of review
• Non-English
• Articles about MP of other organs
• Full version inaccessible
Data extraction and analysis
The data from the included studies was assessed, with the main focus
of these articles being the Materials and Methods section. The primary
aim of this study was to investigate the manner in which the methodol-
ogy of these studies was reported and to determine how certain aspects
concerning the MP procedure were mentioned. The recommendations
and guidelines that this review provides were extensively discussed and
agreed on by all authors of this paper.
Results
Of the 2265 articles identified from the initial literature
search, 127 of these ultimately met all inclusion criteria
(Figure 1). These papers were published between 1997
and 2015 and constituted both animal and human clinical
studies. From our analyses, we observed several differ-
ences in the manner in which the same type of MP tech-
niques was referred to as well as marked variation in the
temperatures used. In the following paragraphs and
tables, we highlight and assess these differences as well
as provide recommendations to establish uniformity in
the manner in which data are reported.
Timing of machine perfusion
In all of the studies reviewed in this paper, MP was con-
ducted either for (almost) the entire duration of the
preservation phase of the transplantation process or
before or after a period of traditional SCS. A significant
majority of the research groups that conducted animal
studies (3–34) and studies in which the donor and recipi-
ent center was the same location (35) nearly eliminated
the SCS phase, thus perfusing donor organs immediately
after procurement until the point of implantation. The
remaining studies, particularly most human studies,
performed MP for various time periods after a few hours
of SCS (during transport of the organs from the donor to
recipient centers) or as a result of prolonged cold ische-
mia times due to various logistical or unforeseen circum-
stances (36–50). Interesting to note, as opposed to
performing MP for the entire preservation phase, the
first clinical studies conducted by Guarrera et al. and
Dutkowski et al. chose to focus on exclusively conduct-
ing MP after a period of traditional SCS and immediately
prior to implantation (<2 h prior) (35,40,45,46,51).
Nomenclature and abbreviations used to identify the
type of machine perfusion
As the pioneering technique of MP, a number of differ-
ent terms, as shown in Table 1, have been used to
describe hypothermic MP in the past two decades. Even
though the majority of the studies mention the term hy-
pothermic within the title and/or article itself, a number
of papers simply use the term machine perfusion, with-
out specific indication of the temperature used. Other
types of MP include subnormothermic and normothermic
perfusion. For all three major types of MP, despite refer-
ring to the same procedure, numerous abbreviations are
used to describe the type of MP performed (Table 1).
Additionally, for subnormothermic and normothermic
MP, a major difference lay in the additional emphasis of
whether these perfusions were performed extra corpore-
ally or not.
Temperatures used during machine perfusion
Although, in general, three types of MP can be recog-
nized (i.e. hypothermic, subnormothermic and normother-
mic), we noted marked inconsistency in the actual
temperatures denoted by these terms (see Table 2).
Despite including a description of the technique of MP, a
number of papers (7,15,52,53) failed to specify what par-
ticular temperatures were used in their respective stud-
ies while some descriptions used arbitrary and unspecific
Table 1: Nomenclature and abbreviations currently used for the different types of liver machine perfusion
Type of machine perfusion References
Hypothermic (oxygenated) machine perfusion (HMP) 1–8,15,22,24,26,30,31,35,41–46,48–50,56,71,72,80,82,88–99
Hypothermic oxygenated perfusion (HOPE) 8,9,13,34,51,61,100–107
Continuous hypothermic oxygenated machine perfusion (CHOP) 108
Machine perfusion (MP) or Machine perfusion preservation (MPP) 53,57,63,64,73–75,109–111
Cold perfusion 23
Subnormothermic machine perfusion (SMP) 11,112
Subnormothermic machine perfusion (SNMP) 3,10,18,39,76,113–115
Subnormothermic ex vivo liver perfusion (SNEVLP) 17
Subnormothermic machine perfusion (MP20) 60,65–67,116–118
Normothermic machine perfusion (NMP) 16,19,21,25,29,36–38,40,62,68,81,119–123
Normothermic extracorporeal perfusion (NELP) 12,14,77,124,125
Normothermic extracorporeal perfusion (NECMO) 83
Normothermic ex vivo liver perfusion (NEVLP) 5
Warm perfusion 33,54,55,62
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terms such as “warm,” “cold,” or “room temperature”
(23,33,39,54,55) to denote the temperatures used during
MP. Of the 58 studies on hypothermic MP, 26 (45%)
reported perfusing the livers at 4°C, whereas the rest
performed MP at different temperatures within the 0°C–
10°C range. All studies on subnormothermic MP were
generally conducted at temperatures between 20°C and
30°C. However, the majority of these studies reported
using 20°C or 21°C, which in all cases the authors
referred to as being room temperature. Normothermic
MP was primarily carried out at the physiological body
temperature of humans or the animal of study, although
small discrepancies were seen in the temperatures sta-
ted as being the physiological body temperature of the
different animals.
Other aspects of methodology
In addition to the discrepancies in temperature, analysis of
the literature exhibited variation in the description of cer-
tain technical aspects of the machine perfusion procedure.
For instance, seven studies lack a clear description of
whether the liver underwent single (via the hepatic artery
or portal vein) or dual perfusion (16,23,24,56–59). As
opposed to the vast majority (92%) of the studies that stip-
ulated the use of a pressure or flow controlled system and
provided specifications of the settings used, a number of
studies failed to specify this (7,12,16,24,56,59–65). All
studies that provided oxygenation during MP explicitly sta-
ted this in the methodology; however, a number of studies
went further to specifically outline the details such as the
O2/CO2 mixture or the oxygen tension (2,3,5,6,44,64–78)
as opposed to simply mentioning the presence of an
oxygenator within the MP system (6,11,18,20,22,24,59,
60,62,64–68,79–81). Lastly, a significant number of the
studies also clearly mentioned the type of pump used dur-
ing MP (2,3,5,6,26,64–67,69–78,82–84), which gives an
indication of the flow pattern through the liver.
Discussion
In an effort to initiate and facilitate a standardization of
nomenclature as well as to establish guidelines on the
experimental and clinical reporting of MP of donor livers,
this systematic literature review assessed the differ-
ences in the nomenclature, temperatures and techniques
currently used and reported in published articles.
The timing of machine perfusion
Given that the timing and duration of MP during the
entire preservation and transportation period is essen-
tially correlated to the specific benefits MP is intended to
provide to the organ, it is important that the period at
which MP is performed is specified, for instance, organ
reconditioning and optimization can be applied either
prior to or after static cold storage, whereas viability test-
ing is generally performed shortly before implantation.
It is evident from the reviewed literature that MP can be
performed mainly at three particular time points; (1)
immediately after organ procurement, before the organ
is stored on ice for transportation (prestatic cold storage);
(2) (shortly) before organ implantation, especially in
instances with longer cold ischemia times (poststatic cold
storage); and (3) for the entire preservation period
between procurement and implantation, thus (nearly)
eliminating the need for SCS. In the case of the latter
method, we propose the term preservation MP. When
applying preservation MP, a short period of SCS is still
required during and immediately after organ procurement,
when the organ is prepared for connection to the perfu-
sion device, and shortly before implantation to avoid
warm ischemia during the anastomosis time. We thus
propose to use the term preservation MP when the time
period of SCS either before or after MP is less than a
maximum of 3 h (Figure 2). This 3-h time frame is based
on the experience of the authors of this paper with vari-
ous techniques of machine perfusion. It was generally
agreed that in reality it normally takes approximately 1.5–
2 h from the point of in situ cold flush, donor hepatec-
tomy, back table procedure to connection of the organ
onto the perfusion device. However, there are a number
of cases in which this may be delayed, for example, in liv-
ers with aberrant arterial vasculature that require vascular
reconstructions, and thus extra back table time is needed
Table 2: Various temperatures currently used for the different
types of liver machine perfusion
References
Hypothermic temperatures
0°C–4°C 126
1°C–3°C 127
2°C  1°C 119
3°C–5°C 50
3°C–6°C 47,48
4°C 4,8,50,53,74,75,78,100,110,111
4°C–6°C 27,29,30,41,63
4°C–8°C 12,21,63
5°C 121
5°C–8°C 122–125
8°C 60,61
8°C–10°C 77
10°C 24,49,53–57,83,126
Subnormothermic temperatures
20°C 68,80,81,93,95,96,121,127
21°C 11,69,70,78,82,88,89,128
25°C 71
33°C 90
20°C–30°C 94
Normothermic temperatures
Porcine 38°C 100,101,106,116
Human 35.5°C–37.5°C 76
Rat 36.5°C–37°C 129
Human/rabbit/rat 37°C 9,52,74,75,102–105,110,114,130
Rat 37.5°C 14,121,125
(Porcine) 39°C 97
“Warm” 33,52
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before the liver can be connected to the device. This 3-h
time frame is therefore the recommended maximum time
period that allows for unavoidable circumstances that
may cause a delay before machine perfusion can be
started. Similarly, it generally takes 40–60 min to make
the vascular anastomoses in the recipient until reperfu-
sion can be initiated. When this is added to the time
needed to take a donor liver off the machine, flush out
machine perfusion fluid, remove the cannulas and per-
form the last back table work (i.e. trimming of vessels
and preparation of the venacava in the donor for piggy
back anastomosis), one may expect a total time period
of 1–3 h before graft reperfusion in the recipient
occurs. Therefore, this 3 h of SCS reflects a maximum
time period. If the duration of SCS is longer than 3 h
and MP is applied either prior (immediately after
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Figure 2: Charts illustrating classification of the timing of machine perfusion. MP conducted within 3 h of organ procurement and
followed by a period of SCS is considered as pre-SCS MP, whereas that performed after a period of at least 3 h of SCS preservation prior
to implantation is considered as post-SCS MP. Additionally, MP can be performed between periods of SCS. Duration of SCS and preserva-
tion MP conducted within the 3 h windows on either end of the procedure remains unspecified and can be widely varied. Lastly, MP can
also be performed for the entire preservation period (immediately after organ procurement until just before implantation).
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Figure 3: Graphic presentation of the change in the rate of metabolism with decreasing temperature. Based on Van’t Hoff’s
principle (expressed as Q10 ¼ k2=k1ð Þ10=ðt2t1Þ), this graph demonstrates the significantly reduced metabolism at hypothermic tempera-
tures (0°C–12°C). The vertical lines in the graphs indicate the lower endpoint of temperature ranges of the different types of MP
proposed. NMP; normothermic machine perfusion (35°C–38°C); SMP, subnormothermic machine perfusion (25°C–34°C); MMP,
mid-thermic machine perfusion (13°C–24°C); HMP, hypothermic machine perfusion (0°C–12°C).
2936 American Journal of Transplantation 2016; 16: 2932–2942
Karangwa et al
procurement) or after SCS (shortly before implantation),
we propose to call this pre-SCS MP and post-SCS MP,
respectively.
Nomenclature and abbreviations
A number of different terms and abbreviations have been
used in the observed studies describing generally similar
MP methods. In some of these cases, a few aspects
such as oxygenation or single/dual perfusion may have
differed and were incorporated. To minimize confusion
and tackle the heterogeneity in the nomenclature, we
believe that authors of future publications should avoid
adapting other aspects of perfusion into the nomencla-
ture and retain simplicity. Given the importance of speci-
fying certain aspects of MP performed, the choice to use
certain terms in the title and throughout the publication
remains within the discretion of the author, although it is
advised that the use of the standardized abbreviations
for the respective types of MP—HMP (hypothermic
machine perfusion), MMP (mid-thermic machine perfu-
sion), SMP (subnormothermic machine perfusion) and
NMP (normothermic machine perfusion)—be maintained.
Temperature ranges
As described in the Results section, experiments con-
ducted on MP of donor livers have generally been per-
formed at three temperature ranges: hypothermically at
0°C–10°C,subnormothermically at 20°C–33°C and nor-
mothermically at 35°C–38°C (depending on the species
used in study). Based on common practice of the various
research groups working on liver MP and following a dis-
cussion with the authors involved in this review, the fol-
lowing classification of the standardized temperature
ranges is proposed.
Hypothermic MP (0°C–12°C): All studies involving HMP
so far have been conducted at temperatures of 10°C
and below with the major reason being that the rate of
metabolism and enzymatic reactions in mammalian cells
decreases to rates as low as 20% or even less (85,86)
(Figure 3). The benefit of HMP is that it minimizes
preservation injury while improving organ viability and,
for oxygenated livers, replenishes adenosine tri-
phosphate (ATP) stores. Because the rates of numerous
energy dependent reactions of liver mitochondrial
enzymes exhibit a significant change at 12.5°C (87), the
proposed cut-off point for HMP is 12°C.
Midthermic MP (13°C–24°C) and subnormothermic
MP (25°C–34°C): The term subnormothermic has been
considered for temperature ranges varying between
12°C and 35°C even though MP was performed at
20°C–22°C in the majority of studies in which the
temperature was referred to as subnormothermic. This
broad temperature range shows a great difference in the
rate of metabolism at, for example, 12°C as compared to
33°C (Figure 2). Furthermore, it can be argued that
temperatures as low as 15°C, 18°C or 20°C are too low
to be considered as subnormothermic as not only does
this term suggest being slightly below normal body
temperature but also at such low temperatures a living
person would be defined as (extremely) hypothermic.
Whereas at higher temperatures such as 30°C–33°C, the
rate of metabolism increases close to 70% of the normal
rate at body temperature (Figure 3). Based on this,
we propose to use the term mid-thermic (13°C–24°C)
to distinguish the lower temperatures (0°C–12°C) from
the less physiologically abnormal subnormothermic
temperature range (25°C–34°C).
Table 3: Checklist with recommended guidelines for the
reporting of relevant aspects of the methodology used in liver
machine perfusion
1. Phase of
preservation
 Timing
○ Pre-SCS MP
○ Preservation MP
○ Post-SCS MP
 Duration of MP
○ Specified in hours/minutes
2. Environment
and temperature
 In situ
○ (Normothermic) Regional perfusion
 Ex situ:
○ Hypothermic MP (0°C–12°C)
○ Midthermic MP (13°C–24°C)
○ Subnormothermic MP (25°C–34°C)
○ Normothermic MP (35°C–38°C)
3. Technical
aspects
 Single or dual vessel perfusion
(hepatic artery/portal vein)
○ Continuous or pulsatile flow
 Pressure or flow controlled perfusion
○ Computerized or manually
controlled system
 Perfusion temperature
○ Specify temperature in °C
○ Specify any significant
temperature changes during MP
(e.g. gradual rewarming)
 Temperature control
○ Automated or manual
 Type of pump
○ Roller/centrifugal/peristaltic
4. Perfusion fluid
composition and
oxygenation
 Perfusion fluid components
○ Full description of the composition
of the perfusion fluid used1
 Oxygenation
○ Ambient air, pure (100%) oxygen,
or carbogen, other mixture
 Heparin, antibiotics and nutrients
 Any other interventions e.g. drugs
5. Pre- and
Post-MP phase
 Is organ flushed before and/or after MP?
○ Which fluid is used and how much?
○ At what temperature?
 Specify vessels used in flushing of
the organ
1Both at baseline as well as compounds that are continuously or
intermittently administered during perfusion.
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Normothermic MP (35°C–38°C): The term normo-
thermic should refer to the normal core body temperature
of the species used in the study, i.e. 37°C for human and
rodent studies and 38°C in studies with porcine models.
Ex vivo or ex situ MP
An additional aspect of MP that demonstrated particular
variation in the literature was the referral of MP as being
performed ex vivo or ex situ. Given that MP involves per-
fusion of donor livers outside the body of a deceased
donor, the term ex vivo, which refers to “outside of the
living body,” does not seem appropriate. Therefore, the
term ex situ, which refers to “outside original location/
position,” is proposed as a more representative descrip-
tion of what occurs during MP.
Other technical aspects and reporting guidelines
Along with discrepancies in the nomenclature and tem-
perature ranges, reporting of other aspects, particularly
technical aspects belonging to methodology, were
observed. Given the ongoing advancement in the field
of MP, it is important that certain methodological
aspects are explicitly stated to ensure that studies can
be reproduced as well as objectively compared with
each other. Moreover, with additional clinical trials cur-
rently being performed, this will facilitate future meta-
analyses with maximum validity and reliability. The
authors of this review reached a consensus on various
aspects of the MP procedure that were considered fun-
damental and developed a checklist that can be utilized
and referred to when preparing a report on liver MP
(Table 3). Important aspects in this checklist include
clear descriptions of the flushing technique, all of the
technical aspects of the MP procedure, type of perfu-
sion fluid used and clarification of the time point, dura-
tion and temperatures at which MP is conducted.
Furthermore, to make valid comparisons of experimental
outcomes, the manner in which data is presented and
described, particularly in the Results section of publica-
tions, is important. The selection of (clinically) relevant
endpoints during MP was not the objective of this
paper, but the reader is referred to other recent reviews
that have summarized the various types of biomarkers
that can be used during MP for graft viability assess-
ment (69,70). Naturally, in clinical trials traditional out-
come parameters such as graft and patient survival
rates, as well as hepatic and systemic postoperative
complications, will be relevant endpoints. In case of
donation after cardiac death (DCD) liver transplantation,
a major clinical endpoint should be the incidence of
postoperative biliary complications.
Conclusion
As experimental and clinical research into MP of donor
livers advances, a standardization of nomenclature and
reporting of technical aspects of MP is required to mini-
mize heterogeneity and to facilitate more reliable and
valid comparison analyses of studies. We hope this
paper provides a useful overview on current nomencla-
ture and will be helpful in the reporting of future research
studies on liver MP.
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